Free Trial

Craneware (LON:CRW) Sets New 52-Week Low - Here's Why

Craneware logo with Medical background

Craneware plc (LON:CRW - Get Free Report) shares hit a new 52-week low on Thursday . The stock traded as low as GBX 1,670 ($21.26) and last traded at GBX 1,678.40 ($21.36), with a volume of 5047 shares. The stock had previously closed at GBX 1,720 ($21.89).

Wall Street Analysts Forecast Growth

CRW has been the topic of several analyst reports. Shore Capital reissued a "buy" rating on shares of Craneware in a research report on Tuesday, March 11th. Berenberg Bank reiterated a "buy" rating and set a GBX 2,800 ($35.64) target price on shares of Craneware in a report on Tuesday, March 11th.

View Our Latest Stock Report on CRW

Craneware Trading Up 1.0 %

The business has a fifty day moving average price of GBX 1,860.52 and a 200-day moving average price of GBX 2,030.39. The company has a quick ratio of 1.00, a current ratio of 0.63 and a debt-to-equity ratio of 12.22. The company has a market cap of £672.43 million, a P/E ratio of 57.82 and a beta of 0.28.

Craneware Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, April 17th. Stockholders of record on Thursday, March 20th will be issued a dividend of GBX 13.50 ($0.17) per share. The ex-dividend date of this dividend is Thursday, March 20th. This represents a dividend yield of 0.71%. Craneware's dividend payout ratio is presently 107.14%.

About Craneware

(Get Free Report)

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.

Featured Stories

Should You Invest $1,000 in Craneware Right Now?

Before you consider Craneware, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.

While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines